
Ernexa Therapeutics Inc.
ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31
Reports and events: 422 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-04-1617:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-21-013151 |
| 2021-04-1517:20 ET | 8-K | 1.01 Entry into a material agreement | 0001140361-21-012968 |
| 2021-04-0717:18 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-012036 |
| 2021-03-3117:18 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-011095 |
| 2021-03-2317:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-006655 |
| 2021-03-1716:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001214659-21-003229 |
| 2021-03-1616:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001214659-21-003181 |
| 2021-03-1619:39 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-006033 |
| 2021-03-1117:07 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001493152-21-005827 |
| 2021-03-0807:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-005525 |
| 2021-02-2616:32 ET | 8-K | 8.01 Other events | 0001493152-21-004937 |
| 2021-02-2507:02 ET | 8-K | 8.01 Other events | 0001493152-21-004770 |
| 2021-02-2216:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001214659-21-002194 |
| 2021-02-0916:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-003076 |
| 2021-02-0418:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-002556 |
| 2021-01-2916:25 ET | SC 13D | Ownership report, active investor | 0001214659-21-000983 |
| 2021-01-1517:22 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-21-001197 |
| 2020-11-2307:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-20-022176 |
| 2020-11-1317:00 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001493152-20-021342 |
| 2020-11-1306:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-20-021217 |
| 2020-11-0508:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-20-020534 |
| 2020-09-1817:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-018033 |
| 2020-08-1817:12 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-20-022708 |
| 2020-08-1417:16 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-015948 |
| 2020-08-1306:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-015415 |
| 2020-08-1216:55 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-20-015356 |
| 2020-08-0718:47 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001493152-20-014994 |
| 2020-08-0706:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-20-014915 |
| 2020-07-0108:00 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-20-012355 |
| 2020-06-1706:30 ET | 8-K | 8.01 Other events | 0001493152-20-011316 |
| 2020-06-1516:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-20-011179 |
| 2020-06-1506:03 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-20-011129 |
| 2020-06-0413:56 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-20-010546 |
| 2020-06-0216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-010400 |
| 2020-05-2016:16 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001493152-20-009524 |
| 2020-05-1916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-20-009409 |
| 2020-04-2717:00 ET | 10-K/A | Annual report, amendedPeriod 2019-12-31 | 0001493152-20-007162 |
| 2020-04-2116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-006840 |
| 2020-04-0316:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-20-005788 |
| 2020-03-3016:15 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-005216 |
| 2020-03-1916:18 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001493152-20-004343 |
| 2020-03-1716:20 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-20-004153 |
| 2020-01-1516:15 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-000627 |
| 2020-01-0816:57 ET | SC 13D/A | Ownership report, active investor, amended | 0001062993-20-000077 |
| 2019-11-2608:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-19-018405 |
| 2019-11-0116:11 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001493152-19-016324 |
| 2019-10-3016:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-19-016200 |
| 2019-09-1716:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-19-014223 |
| 2019-09-0306:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-19-013592 |
| 2019-08-1216:31 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001493152-19-012078 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.